-
-
-
-
-
-
-
Genmab Announces Financial Results for the First Half of 2025
-
-
-
-
-
-
-
Genmab Updates 2024 Financial Guidance
-
-
-
-
-
-
-
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
-
-
-
-
-
-
-
Genmab Announces Financial Results for the First Nine Months of 2023
-
-
-
-
-
-
-
Genmab A/S (GMAB) Improves FY22 Financial Guidance
-
-
-
-
-
-
-
Genmab Announces Financial Results for the First Quarter of 2021
-
-
-
-
-
-
-
Passing of Genmab A/S’ Annual General Meeting
-
1,198,731 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

